Szemészet, 2015 (152. évfolyam, 1-4. szám)

2015-09-01 / 3. szám

Primary melanocytic lesions of the conjunctiva

4. Damato B, Coupland SE. Clinical mapping of conjunctival melanomas. Br J Ophthalmol 2008; 92(11): 1545-1549.

5. Damato B, Coupland SE. An audit of conjunctival melanoma treatment in Liverpool. Eye (Lond) 2009; 23: 801-809.

6. Damato B, Coupland SE. Management of conjunctival melanoma. Expert Rev Anticancer Ther 2009; 9(9): 1227-1239.

7. de Rojas V, Gestoso A, Lopez I, et al. Anterior segment optical coherence tomography in corneal and conjunctival pathology. J Emmetropia 2012; 3: 177-192.

8. Edge SB, Byrd DR, Compton CC, Frtiz AG, Greene FL, Trotti A. (eds) Malignant melanoma of the conjunctiva. In: AJCCCancer Staging Manual, 7th edition. New York: Springer; NY 2010; pp. 539-546.

9. Esmaeli B, Wang X, Youssef A, Gershenwald JE. Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades. Ophthalmology 2001; 108(11): 2101-2105.

10. Finger PT, Czechonska G, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 1998; 82: 476-479.

11. Folberg R, Jacobiek FA, Bernardino VB, Iwamoto T. Benign conjnctival melanocytic lesions. Clinicopathologic features. Ophthlamology 1989; 96: 436-461.

12. Folberg R, McLean IW. Primary acquired melanosis and melanoma of the conjunctiva: terminology, classification, and biologic behavior. Hum Pathol 1986; 17(7): 652-654.

13. Folberg R, McLean IW, Zimmermann IE. Primary acquired melanosis of the conjunctiva. Hum Pathol 1985; 16: 129-135.

14. Jakobiec FA, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 1989; 96: 147-166.

15. Keijser S, Missotten GS, Bonfrer JM, et al. Immunophenotypic markers to differentiate between benign and malignant melanocytic lesions. Br J Ophthalmol 2006; 90(2): 213-217.

16. Kenawy N, Lake SL, Coupland SE, Damato BE. Conjunctival melanoma and melanocytic intraepithelial neoplasia. Eye 2013; 27: 142-152.

17. Kurli M, Finger PT. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience. Graefes Arch Clin Exp Ophthalmol 2005; 243(11): 1108-1114.

18. Lake SL, Jmor E Dopierala J, Taktak AF Coupland SE, Damato BE. Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sei 2011; 52(8): 5598-5604.

19. Lim LA, Madigan MC, Conway RM. Conjunctival melanoma: a review of conceptual and treatment advances. Clin Ophthalmol 2013; 6: 521-31.

20. Lommatzsch PK, Lommatzsch RE, Kirsch I, Fuhrmann P Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol 1990; 74(10): 615-619.

21. Missotten GS, Keijser S, De Keizer RJ, De Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sei 2005; 46(1): 75-82.

22. Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radio —"therapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 1996; 234(9): 569-572.

23. Oellers P Krapp CL. Management of pigmented conjunctival lesions.

Ocul Surf 2012; 210: 251-263.

24. Paridaens AD, Minassian DC, McCartney AC, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol 1994; 78(4): 252-259.

25. Pavlin CJ, Vásquez LM, Lee R, Simpson ER, Ahmed II. Anterior segment optical coherence tomography and ultrasound biomicroscopy in the imaging of anterior segment tumors. Am J Ophthalmol 2009; 147:214-19.

26. Savar A, Ross Ml, Prieto VG, Ivan D, Kim S, Esmaeli B. Sentinel lymph mode biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology 2009; 116: 2217-2223.

27. Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998; 42(4): 321-350.

28. Shields CL, Belinsky I, Romanelli-Gobbi M et al. Anterior segment optical coherence tomography of conjunctival nevus. Ophthalmology 2011; 118: 915-19.

29. Shields CL, Fasiuddin AF Mashayekhi A, Shields JA. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol 2004; 122: 167-75.

30. Shields CL, Oemirci H, Karatza E, Shields JA. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology 2004; 111(9): 1747-1754.

31. Shields CL, Markowitz JS, Belinsky I, et al. Conjunctival melanoma. Outcomes based on tumor origin in 382 consecutive cases. Ophthalmology 2011; 118: 389-395.

32. Shields JA, Shields CL, Mashayekhi A, Marr BR Benavides R, Thangappan A, Phan L, Eagle RC Jr Primary acquired melanosis of the conjunctiva: experience with 311 eyes. Trans Am Ophthalmol Soc 2007; 105: 61-72.

33. Shousha MA, Karp CL, Canto AR et al. Diagnosis of ocular surface lesions using ultra-high-resolution optical coherence tomography. Ophthalmology 2013; 120: 883-91.

34. Spendlove HE, Damato BE, Humphreys J, Barker KT, Hiscott PS, Houlston RS. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res 2004; 14(6): 449-452.

35. Tóth-Molnár E, Hammer H, Tiszlavicz L, Tálosi L. Kifejezett malignitésú non-Hodgkin T-sejtes lymphomás betegben kialakult melanoma malignum conjunctivae. Szemészet 2000; 137: 209-211.

36. Tóth-Molnár E, Oláh J, Dobozy A, Hammer H. Ocular pigmented findings in patients with dysplastic naevus syndrome. Melanoma Res 2004; 14(1): 43-7.

37. Triay E, Bergman L, Nilsson B, All-Ericsson C, Seregard S. Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol 2009; 93(9): 1524-1528.

38. Tuomaala S, Kivelä T. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 2004; 111(4): 816-821.

39. Tuomaala S, Toivonen R Al-Jamal R, Kivelä I Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res 2007; 32(11): 939-952.

40. Werschnik C, Lommatzsch PK. Long-term follow-up of patients with conjunctival melanoma. Am J Clin Oncol 2002; 25(3): 248-255.

41. Zembowicz A, Mandal RV, Choopong R Melanocytic lesions of the conjunctiva. Arch Pathol Lab Med 2010; 134: 1785-1792.

42. Zimmerman LE, Sobin LH. Histologic typing of tumors of the eye and its adnexa. In: International histologic classification of tumors. Geneva, Zurich: World Health Organization; 1980. p. 23-24.

Levelezési cím

Dn Tóth-Molnár Edit, Szegedi Tudományegyetem, Szemészeti Klinika 6720 Szeged, Korányi Fasor 10-1.1. E-mail: tme@tmedit.hu